Dublin, Dec. 19, 2016 -- Research and Markets has announced the addition of the "Global Gynecology Robotic Surgery Market 2016-2020" report to their offering.
The global gynecology robotic surgery market to grow at a CAGR of 10.07% during the period 2016-2020.
Global Gynecology Robotic Surgery Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. To calculate the market size, the report considers the revenue generated from the sales various robotic platforms used for gynecology applications.
According to the report, the limitations involved in open surgeries have driven the adoption of gynecological surgical robots. The open abdomen surgery for gynecology and laparoscopic surgeries require large incisions and longer recovery times, which affect the individual's outcome. Also, the procedure is associated with the increased infection rates and increased blood transfusion rates. Therefore, the surgeons are increasingly adopting surgical robots owing to its benefits over open surgeries. Some of the advantages of surgical robots include, reduction of incision size, fewer blood transfusions, and improved recovery times. Further, the robotic surgery enhances surgeon's skills, reduces variability, and provides opportunities for simulation.
At present, the market is dominated by Intuitive Surgical due to its da Vinci surgical system, though there is intense competition between Titan Medical that developed the SPORT surgical system and Intuitive Surgical. Titan Medical has a high market share in Europe, and it is expected to penetrate the US market by mid-2017 by getting approval for its SPORT surgical system. TransEnterix has developed the ALF-X robotic surgical system, which it acquired in September 2015 through the acquisition of a robotic division of SOFAR S.p.a worth $99.8 million. The company also developed TELELAP ALF-X surgical robotic system, a CE-marked device available in Europe.
Key vendors
- Intuitive Surgical
- Titan Medical
- TransEnterix
Other prominent vendors
- AVRA Surgical Robotics
- NovaTract Surgical
- OmniGuide Holdings
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Market segmentation by product
Part 07: Market segmentation by applications
Part 08: Market segmentation by end-users
Part 09: Geographical segmentation
Part 10: Market drivers
Part 11: Impact of drivers
Part 12: Market challenges
Part 13: Impact of drivers and challenges
Part 14: Market trends
Part 15: Vendor landscape
Part 16: Key vendor analysis
Part 17: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/s7mq2t/global_gynecology
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Women's Health, Surgical Procedures


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Washington Post Publisher Will Lewis Steps Down After Layoffs
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



